Contract Services

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human heal...

 November 25, 2021 | News

Immunomic Therapeutics Announces Collaboration With iOncologi

Immunomic Therapeutics, Inc., (“ITI”) a privately held clinical-stage biotechnology company focused on advancing its proprietary nucleic acid i...

 November 24, 2021 | News

OncoOne ,GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF

OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and GenScript ProBio, a leading CDMO in b...

 November 17, 2021 | News

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.&n...

 November 12, 2021 | News

Clinical Ink Acquires Digital Artefacts

 Clinical Ink — a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct — ...

 November 08, 2021 | News

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production Increases up to 60 million vials...

 November 01, 2021 | News

Catalent Further Expands Clinical Supply Network with New Facility in North America

The new facility marks the latest expansion to Catalent’s global clinical supply network, and follows the opening of a new site in Japan earlier this...

 October 29, 2021 | News

Xcell Therapeutics opens an export route for cell therapy culture technology.

In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...

 October 29, 2021 | News

Merck Drives New Innovation & Adds Capacity to Advance Next Generation (ADC) Therapies

Merck's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges  - New DOLCORE™ platform inc...

 October 29, 2021 | News

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...

 October 28, 2021 | News

Samsung Biologics Reports Third Quarter 2021 Financial Results

Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compa...

 October 27, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

  Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

 October 26, 2021 | News

BD launches its second center of excellence in flow cytometry for clinical research at CMC In India

The CoE at CMC Vellorewill help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis with highe...

 October 25, 2021 | News

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

 October 25, 2021 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in